NCT06684028

PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Affiliated Hospital of Jiangnan University · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.

Detailed description

PET/CT imaging was performed about 1 hour after the patient was injected with the novel tracer 68Ga-FAPI-JNU. SUVmax and SUVmean values of the area of interest were mapped by two diagnostic physicians with more than 5 years of experience after the imaging was completed.

Conditions

• Cancer
• Solid Malignancies

Interventions

Type	Name	Description
DRUG	68Ga-FAPI-JNU	Patients will receive the novel tracer 68Ga-FAPI-JNU dose of approximately 2-5 mCi per person

Timeline

• Start date: 2023-07-12
• Primary completion: 2025-07-31
• Completion: 2025-07-31
• First posted: 2024-11-12
• Last updated: 2025-01-22

Locations

1 site across 1 country: China